CHRM3 and pancreatic neoplasm: This discrepancy might stem from the fact that different receptors were activated by acetylcholine; while activation of M3 muscarinic receptor has been shown to promote gastric and colon cancer progression, activation of M1 muscarinic receptor, on the other hand, inhibited pancreatic cancer cell proliferation [67,68].